Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OCUL | GENB |
|---|---|---|
| Price | $7.25 | $13.91 |
| Change today | ▲ 4.17% | ▲ 1.61% |
| Market cap | $1.59B | $1.79B |
| Return, 3 months | -29.8% | -14.2% |
| Return, year to date | -40.3% | – |
| Return, 1 year | -33.9% | – |
| P/E (TTM) | -5.2 | -6.6 |
| P/B | 3.1 | 3.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -18.5% | – |
| Net profit growth (YoY) | -37.4% | – |
| Gross margin | 87.3% | – |
| Operating margin | -519.8% | – |
| Net margin | -511.9% | – |
| Return on equity | – | – |
| Analyst target vs. price | +252.7% | +86.9% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 29 | 38 |
| 30-day volatility | 84.0% | 99.4% |
| Max drawdown, 1 year | -57.3% | -32.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
